Cytokinetics, Incorporated
$72.09
-5.81 (-7.46%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -10.4%
- 3 Months
- -6.1%
- YTD
- +13.5%
- 1 Year
- +90.6%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 60.5%
- Largest decline max drawdown, since Aug 2025
- -17.4%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.34
Own CYTK?
See how CYTK contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.